SPIMACO

Saudi Pharmaceutical Industries & Medical Appliances Corp.

2070StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Market & Price
Market Capitalization	3.57B	3.83B	4.54B	2.61B	4.72B
Market Cap Growth	+2.9%	-15.5%	+73.6%	-44.7%	+0.4%
Enterprise Value	4.81B	5.22B	5.56B	3.53B	5.39B
Last Close Price	29.94	31.95	37.80	21.78	38.65
Valuation Multiples
Forward PE (Next 12M Est.)	19.66	29.44	54.19	62.57	25.66
PE Ratio	27.73	156.27	—	—	178.50
PS Ratio	2.12	2.28	2.74	1.84	3.24
PB Ratio	2.09	2.50	2.99	1.54	2.37
P/TBV Ratio	2.46	3.06	3.45	1.76	2.67
P/FCF Ratio	30.02	—	—	—	451.01
P/OCF Ratio	19.78	—	417.18	—	54.46
EV/Sales Ratio	2.86	3.10	3.36	2.49	3.69
EV/EBITDA Ratio	15.43	27.55	42.33	—	47.89
EV/EBIT Ratio	22.23	45.58	93.10	—	164.19
EV/FCF Ratio	40.45	—	—	—	514.92
Leverage & Capital
Debt / Equity Ratio	0.84	0.99	0.74	0.64	0.65
Debt / EBITDA Ratio	5.05	7.82	8.24	—	11.11
Debt / FCF Ratio	12.02	—	—	—	123.67
Net Debt / Equity Ratio	0.63	0.81	0.56	0.41	0.20
Net Debt / EBITDA Ratio	3.81	6.52	6.42	-24.85	3.54
Net Debt / FCF Ratio	9.07	-3.07	-8.79	-3.95	38.09
Efficiency & Liquidity
Asset Turnover	0.38	0.41	0.43	0.34	0.32
Inventory Turnover	1.43	1.40	1.78	1.89	1.93
Quick Ratio	0.92	0.75	0.85	0.95	1.20
Current Ratio	1.43	1.17	1.35	1.39	1.50
Returns & Yields
Return on Equity (ROE)	+8.3%	+2.1%	-2.5%	-8.6%	+1.1%
Return on Assets (ROA)	+2.6%	+1.7%	+1.0%	-1.6%	+0.5%
Return on Invested Capital (ROIC)	+5.5%	+2.0%	-19.3%	-4.5%	+0.9%
Return on Capital Employed (ROCE)	+6.9%	+5.0%	+2.4%	-4.4%	+1.2%
Earnings Yield	+3.6%	+0.6%	-1.1%	-6.3%	+0.6%
FCF Yield	+3.3%	-10.5%	-2.1%	-6.8%	+0.2%
Dividend Yield	—	—	—	—	+1.6%
Payout Ratio	+1.5%	+11.3%	—	—	+446.5%
Buyback Yield / Dilution	+0.2%	+0.1%	+0.3%	—	—
Total Shareholder Return	+0.2%	+0.1%	+0.3%	—	+1.6%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Market & Price
Market Capitalization	3.57B	3.83B	4.54B	2.61B	4.72B
Market Cap Growth	+2.9%	-15.5%	+73.6%	-44.7%	+0.4%
Enterprise Value	4.81B	5.22B	5.56B	3.53B	5.39B
Last Close Price	29.94	31.95	37.80	21.78	38.65
Valuation Multiples
Forward PE (Next 12M Est.)	19.66	29.44	54.19	62.57	25.66
PE Ratio	27.73	156.27	—	—	178.50
PS Ratio	2.12	2.28	2.74	1.84	3.24
PB Ratio	2.09	2.50	2.99	1.54	2.37
P/TBV Ratio	2.46	3.06	3.45	1.76	2.67
P/FCF Ratio	30.02	—	—	—	451.01
P/OCF Ratio	19.78	—	417.18	—	54.46
EV/Sales Ratio	2.86	3.10	3.36	2.49	3.69
EV/EBITDA Ratio	15.43	27.55	42.33	—	47.89
EV/EBIT Ratio	22.23	45.58	93.10	—	164.19
EV/FCF Ratio	40.45	—	—	—	514.92
Leverage & Capital
Debt / Equity Ratio	0.84	0.99	0.74	0.64	0.65
Debt / EBITDA Ratio	5.05	7.82	8.24	—	11.11
Debt / FCF Ratio	12.02	—	—	—	123.67
Net Debt / Equity Ratio	0.63	0.81	0.56	0.41	0.20
Net Debt / EBITDA Ratio	3.81	6.52	6.42	-24.85	3.54
Net Debt / FCF Ratio	9.07	-3.07	-8.79	-3.95	38.09
Efficiency & Liquidity
Asset Turnover	0.38	0.41	0.43	0.34	0.32
Inventory Turnover	1.43	1.40	1.78	1.89	1.93
Quick Ratio	0.92	0.75	0.85	0.95	1.20
Current Ratio	1.43	1.17	1.35	1.39	1.50
Returns & Yields
Return on Equity (ROE)	+8.3%	+2.1%	-2.5%	-8.6%	+1.1%
Return on Assets (ROA)	+2.6%	+1.7%	+1.0%	-1.6%	+0.5%
Return on Invested Capital (ROIC)	+5.5%	+2.0%	-19.3%	-4.5%	+0.9%
Return on Capital Employed (ROCE)	+6.9%	+5.0%	+2.4%	-4.4%	+1.2%
Earnings Yield	+3.6%	+0.6%	-1.1%	-6.3%	+0.6%
FCF Yield	+3.3%	-10.5%	-2.1%	-6.8%	+0.2%
Dividend Yield	—	—	—	—	+1.6%
Payout Ratio	+1.5%	+11.3%	—	—	+446.5%
Buyback Yield / Dilution	+0.2%	+0.1%	+0.3%	—	—
Total Shareholder Return	+0.2%	+0.1%	+0.3%	—	+1.6%